Skip to main content

Table 3 Bivariate and multivariate logistic regression of ED with predictor variables among diabetic patients in Hawassa city, Jan 2018

From: Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia

Variable Erectile Dysfunction COR(95%CI) AOR(95%CI p value
Yes No
Age
 15–25 3 15 1 1  
 26–35 16 19 0.04(0.001–0.023) 0.238(0.026–2.168) 0.04
 36–45 46 44 0.002(0.006–0.082) 0.274(0.026–2.84)  
 45–55 84 18 0.029(0.009–0.098) 0.77(0.072–8.26)  
 > 55 105 2 2.42(1.73–3.83) 3.2(1.32–4.34)*  
Occupation
 Unemployed 38 10 1 1  
 Daily labor 1 4 0.27(0.13–0.69) 1.57(0.095–26.05) > 0.05
 Merchant 62 16 1.02(0.42–2.47) 3.06(0.299–31.33)  
 Gov. employee 78 47 0.437(0.199–0.957) 1.03(0.91–11.75)  
 Private/NGO 26 17 0.402(0.159–1.017) 0.76(0.071–8.26)  
 Farmer 49 4 1.287(0.473–3.496) 0.6(0.04–9.01)  
Marital status
 Single 6 19 1 1  
 Married 233 74 3.5(1.5–8) 7.3(0.937–56.84) > 0.05
 Divorced 7 3 6(1.21–29.72) 11.13(6.22–67.25)  
 Widowed 8 2 4.23(2.27–6.32) 1.63(0.952–5.54)  
Educational status
 No formal education 25 3 1 1  
 Read and write 43 2 2.3(0.48–11.31) 5.66(0.587–54.84) > 0.05
 Primary school 51 14 0.556(0.166–1.855) 1.14(0.155–8.46)  
 High school 70 35 0.32(0.103–0.991) 1.57(0.196–12.71)  
 College and above 65 44 0.215(0.061–0.76) 3.37(0.346–32.98)  
Monthly income (Eth.Birr)
 < 500 birr 15 4 1 1  
 500–1500 birr 114 24 1.6(0.53–4.89) 0.71(0.097–5.32) > 0.05
 1501–2500 birr 58 32 0.21(0.045–0.99) 0.21(0.025–1.86)  
 2501–3500 birr 42 25 0.56(0.18–1.75) 0.29(0.032–2.64)  
 > 3500 birr 25 13 0.612(0.82–2.06) 0.30(0.03–3.03)  
Residence
 Urban 192 83 1 1  
 Rural 62 15 1.92(1–3.69) 1.91(0.67–5.5) > 0.05
Alcohol
 Yes 51 6 0.24(0.093–0.626) 3.23(1.03–10.44)* 0.049
 No 203 92 1 1  
Smoking
 Yes 15 5 1.19(0.42–3.37)   
 No 239 93 1 1 > 0.05
Physical exercise
 Yes 44 58 0.167(0.099–0.282) 0.49(0.23–1.09)  
 No 210 40 1 1 > 0.05
Adherence
 Yes 223 89 0.785(0.369–1.67)   
 No 31 9 1 1 > 0.05
Type of DM
  Type 1 9 14 1 1  
 Type 2 245 84 5.1(2.1–12.5) 1.49(0.22–10.06) > 0.05
Type of hypoglycemic drug
 Oral 133 81 1 1  
 Injectable 121 17 4.04(2.3–7.06) 5.05(1.15–11.23) > 0.05
FBS`
 < 126 67 73 1 1  
 > 126 187 25 8.1(4.78–13.89) 10.3(3.92–27.44)** 0.000
BP    1   
 Normal 35 71 4.06(1.725–9.59) 2.15(0.576–8.07)  
 Elevated 20 10 14.5(7.15–29.4) 0.80(0.348–1.83) > 0.05
 Stage1 HTN 98 13 15.3(7.55–30.98) 1.49(0.42–5.29)  
 Stage2 HTN 101 4 51.2(17.43–150.54) 1  
BMI
 Underweight 0 0    
 Normal 128 86 1 1  
 Overweight 126 12 7.05(0.635–1.82)   > 0.05
 Obese 0 0    
Diabetic duration
 < 5 yrs. 45 59 1 1  
 5–10 yrs. 102 30 4.45(2.54–7.82) 2.66(1.13–6.27)* 0.025
 > 10 yrs. 107 9 15.5(7.11–34.1) 17.7(6.57–48.01)** 0.001
  1. * Significant at p-value < 0.05. ** Significant at p-value < 0.001